should amtl be defined as a distinct diagnostic entity?
Published 4 years ago • 52 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:57
the potential of the tsafinder tool in hematological oncology
-
1:14
highlights in quality management from ebmt
-
2:09
advances in the management of fit adults with aml
-
5:13
what is a haematologist?
-
1:05:07
euretina case club with prof adnan tufail (nov 10th, 2021)
-
2:49:50
day 5 - year in review - hematology 2021
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
1:14
promising novel agents in aml: menin inhibitors
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
3:07
how age as a prognostic factor affects treatment options for all
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:19
al amyloidosis: mrd negativity
-
0:55
a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
-
5:20
approaching smoldering myeloma
-
3:35
role of the microbiome in gvhd